<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Makaryan V</submitter><funding>NHLBI NIH HHS</funding><pagination>98-112</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12439587</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(3)</volume><pubmed_abstract>Congenital neutropenia is characterized by a reduced neutrophil count, decreased innate immunity and increased susceptibility to recurrent infections. While congenital neutropenia has various genetic causes, recent studies have linked &lt;i>TCIRG1&lt;/i> mutations to this condition. &lt;i>TCIRG1&lt;/i>, a key component of the vacuolar ATPase (V-ATPase) complex, is essential for osteoclast function, but its role in hematopoiesis remains unclear. We previously identified heterozygous &lt;i>TCIRG1&lt;/i> mutations, including R736S, R736C, R736P, and E722D, in individuals with congenital neutropenia. However, the mechanism by which these mutations lead to impaired granulopoiesis remains unknown. To investigate the functional consequences of &lt;i>TCIRG1&lt;/i> mutations, we generated induced pluripotent stem cells (i</pubmed_abstract><journal>Journal of cellular immunology</journal><pubmed_title>Modeling &amp;lt;i&amp;gt;TCIRG1&amp;lt;/i&amp;gt; Neutropenia by Utilizing Patient Derived Induced Pluripotent Stem Cells.</pubmed_title><pmcid>PMC12439587</pmcid><funding_grant_id>R01 HL151629</funding_grant_id><pubmed_authors>Bolyard AA</pubmed_authors><pubmed_authors>Mathieu J</pubmed_authors><pubmed_authors>Kelley ML</pubmed_authors><pubmed_authors>Dale DC</pubmed_authors><pubmed_authors>Hesson J</pubmed_authors><pubmed_authors>Makaryan V</pubmed_authors><pubmed_authors>Lenaeus MJ</pubmed_authors><pubmed_authors>Cavanaugh C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Modeling &amp;lt;i&amp;gt;TCIRG1&amp;lt;/i&amp;gt; Neutropenia by Utilizing Patient Derived Induced Pluripotent Stem Cells.</name><description>Congenital neutropenia is characterized by a reduced neutrophil count, decreased innate immunity and increased susceptibility to recurrent infections. While congenital neutropenia has various genetic causes, recent studies have linked &lt;i>TCIRG1&lt;/i> mutations to this condition. &lt;i>TCIRG1&lt;/i>, a key component of the vacuolar ATPase (V-ATPase) complex, is essential for osteoclast function, but its role in hematopoiesis remains unclear. We previously identified heterozygous &lt;i>TCIRG1&lt;/i> mutations, including R736S, R736C, R736P, and E722D, in individuals with congenital neutropenia. However, the mechanism by which these mutations lead to impaired granulopoiesis remains unknown. To investigate the functional consequences of &lt;i>TCIRG1&lt;/i> mutations, we generated induced pluripotent stem cells (i</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-03T03:00:39.327Z</modification><creation>2026-04-23T03:13:35.958Z</creation></dates><accession>S-EPMC12439587</accession><cross_references><pubmed>40964614</pubmed><doi>10.33696/immunology.7.228</doi></cross_references></HashMap>